Riskpilot← Back to searchSign inGet full accessABBVIE AS
ASActiveOrg 998085497Lilleakerveien 8, 0283 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 201269 employees
Revenue 2024
NOK 600,5M
+28% vs 2023
EBITDA margin
4.9%
+1% vs 2023
Equity ratio
36.7%
Financial strength
Net profit 2024
NOK 27,3M
+5% vs 2023
| Revenue | NOK 600,5M | +28% |
| EBITDA | NOK 29,3M | +1% |
| Net profit | NOK 27,3M | +5% |
| Total assets | NOK 259,3M | +6% |
| Equity | NOK 95,2M | -28% |
| Employees | 69 | — |
Legal name
ABBVIE AS
Org number
998085497
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13. mars 2012
Share capital
NOK 496 667
Employees
69 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Selv eller gjennom hel- eller deleide selskaper, eller gjennom samarbeid med andre selskaper å drive handel, produksjon, forskning, utvikling og markedsføring av produkter og produksjonsteknikker innen bioteknologi, deltakelse i andre selskaper, samt å yte administrative, operasjonelle, finansielle, forretningsmessige og industrielle tjenester til enhver tredjepart, aksjeeier, datterselskap, tilknyttet selskap, herunder også lån, forskudd og garantier, samt annen virksomhet som hermed er forbundet.
Address
Lilleakerveien 8, 0283 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 138 795 | 460 375 | 465 705 | 516 067 | 472 957 | 449 292 | 229 309 | 162 324 | 178 945 | 328 523 | 469 440 | 600 525 |
| Staff expenses | −30 044 | −81 557 | −104 389 | −99 056 | −96 195 | −106 347 | −103 772 | −66 301 | −74 171 | −97 887 | −98 956 | −109 850 |
| EBITDA | 6 302 | 44 725 | 23 824 | 27 022 | 23 214 | 20 060 | 15 630 | 11 134 | 13 380 | 24 217 | 29 063 | 29 288 |
| Depreciation & amort. | −467 | −1 889 | −1 734 | −1 025 | −1 002 | −928 | −488 | −338 | −869 | −625 | −551 | −1 287 |
| EBIT | 5 834 | 42 836 | 22 090 | 25 996 | 22 212 | 19 132 | 15 142 | 10 796 | 12 511 | 23 592 | 28 512 | 28 001 |
| Net financials | 151 | 682 | 266 | 196 | 574 | 634 | 688 | 278 | 87 | 1 521 | 5 570 | 7 332 |
| Profit before tax | 5 985 | 43 518 | 22 356 | 26 192 | 22 786 | 19 766 | 15 831 | 11 074 | 12 598 | 25 113 | 34 082 | 35 333 |
| Tax | 1 974 | 12 735 | 6 689 | 7 514 | 5 484 | 4 525 | 3 413 | 2 062 | 2 658 | 5 976 | 8 159 | 8 064 |
| Net profit | 4 011 | 30 782 | 15 667 | 18 677 | 17 302 | 15 241 | 12 417 | 9 012 | 9 940 | 19 136 | 25 923 | 27 270 |
| Item | 2012 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 136 146 | 208 903 | 132 343 | 141 999 | 151 663 | 147 286 | 297 638 | 161 388 | 137 991 | 229 841 | 244 633 | 259 279 |
| Equity | 45 233 | 37 835 | 28 502 | 47 179 | 44 481 | 59 722 | 72 140 | 59 101 | 69 042 | 105 996 | 131 920 | 95 189 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 72 315 | 171 069 | 103 842 | 94 820 | 107 182 | 87 564 | 225 499 | 102 286 | 68 950 | 123 845 | 112 713 | 164 090 |
| Total debt | 72 315 | 171 069 | 103 842 | 94 820 | 107 182 | 87 564 | 225 499 | 102 286 | 68 950 | 123 845 | 112 713 | 164 090 |
EBITDA margin
4.9%
This company
15.8%
Market median
-69% vs market
20122024
Equity ratio
36.7%
This company
38.2%
Market median
+4% vs market
20122024
Return on equity
28.6%
This company
18.4%
Market median
+55% vs market
20122024
Net profit margin
4.5%
This company
8.1%
Market median
-44% vs market
20122024
Asset turnover
2.32×
This company
1.12×
Market median
+107% vs market
20122024
Debt / equity
1.72×
This company
0.62×
Market median
-177% vs market
20122024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Abbvie Central Finance B.V. | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ABBVIE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emilie Claudine Demare | Board of Directors | 0 companies |
| Linn Kristina Mandahl | Chairman | 0 companies |
| Robert Andrew Michael | Board of Directors | 0 companies |
| Matthew Robert Iles | Chairman | 0 companies |
| Jens Lange | Board of Directors | 0 companies |
| Shitra Irari Amozurrutia Blancas | Board of Directors | 0 companies |
| Kirsti Nyhus | Board of Directors | 0 companies |
| Arnaud Jean Jacques Coint-Bavarot | Board of Directors | 0 companies |